SCRC is in great shape AND is in GREAT HANDS. Our "you know who" IHub is just trying to earn his $25 a week stipend. Mr. Schneiderman is in full control of the business model he has developed. And, you are so right, building a business takes making good decisions and time to develop and implement those decisions. I realize the compounding is driving the business right now but I thought it was interesting when he said he did a taste test with a new application for RapiMeds. This means we could be possibly manufacturing two different RapiMeds formulations to cultivate the huge OTC market in China, not to mention Canada and South America. SCRC's pps is currently up 40% over this time last month and it's just going to get better and better as time progresses.